BPG is committed to discovery and dissemination of knowledge
Correction
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Stem Cells. Feb 26, 2026; 18(2): 116824
Published online Feb 26, 2026. doi: 10.4252/wjsc.v18.i2.116824
Correction to “Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis”
Qiong-Dan Hu, Rui-Zhi Tan, Yuan-Xia Zou, Jian-Chun Li, Jun-Ming Fan, Fahsai Kantawong, Li Wang
Qiong-Dan Hu, Department of Nephrology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan Province, China
Qiong-Dan Hu, Fahsai Kantawong, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
Qiong-Dan Hu, Yuan-Xia Zou, Jian-Chun Li, Li Wang, Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan Province, China
Rui-Zhi Tan, Research Center of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou 646000, Sichuan Province, China
Rui-Zhi Tan, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai 50200, Thailand
Yuan-Xia Zou, Jian-Chun Li, Molecular Imaging and Therapy Research Unit, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
Jun-Ming Fan, Department of Nephrology, The Affiliated Hospital of Chengdu Medical College, Chengdu 610500, Sichuan Province, China
Co-corresponding authors: Fahsai Kantawong and Li Wang.
Author contributions: Kantawong F and Wang L contributed equally to this article as co-corresponding authors; Kantawong F and Wang L designed the study and supervised the laboratory experiments; Hu QD conducted the experiments and drafted the manuscript; Tan RZ assisted with the experiments; Zou YX and Li JC collected the samples; Fan JM and Wang L contributed new reagents and analytic tools; and all authors read and approved the final manuscript.
Supported by the National Natural Science Foundation of China, No. 82205002 and No. 82104662; the Science and Technology Project of Sichuan Province, No. 2022YFS0621; Luzhou-Southwest Medical University Science and Technology Strategic Cooperation Project, No. 2021 LZXNYD-P04; and the Southwest Medical University of Affiliated Traditional Medicine Hospital Project, No. 2022-CXTD-03.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Li Wang, PhD, Professor, Senior Researcher, Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, No. 182 Chunhui Road, Longmatan District, Luzhou 646000, Sichuan Province, China. wangli111@swmu.edu.cn
Received: November 21, 2025
Revised: December 1, 2025
Accepted: January 7, 2026
Published online: February 26, 2026
Processing time: 85 Days and 16.3 Hours
Abstract

This is an erratum to the published paper entitled “Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis”. Upon re-examining our original data, we have identified an error in the assembly of Figure 1F, where the glyceraldehyde-3-phosphate dehydrogenase loading control image was incorrectly placed due to a clerical oversight during figure preparation. This does not reflect any issue with the underlying experimental data.

Keywords: Correction; Calycosin; Mesenchymal stem cells; Focal segmental glomerulosclerosis; Apoptosis; Smad3

Core Tip: This is a correction to “Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis”. Upon re-examining our original data, we identified an error in the assembly of Figure 1F, where the glyceraldehyde-3-phosphate dehydrogenase loading control image was incorrectly placed due to a clerical oversight during figure preparation. As the corresponding author, I am submitting the corrected figure.